An Options Strategy For This COVID Vaccine Play With More Room To Run

When it comes to COVID-19 vaccine manufacturers, the author of today’s article notes “While it’s no surprise that investors have already bought into these companies, there’s still more room to run” – and he proceeds to highlight one particular COVID vaccine play that could net traders a high double-digit return using options. For the company in question and the author’s recommended action to take, CLICK HERE.